Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

IQP-GC-101

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Objective This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2017
2017
Irritable bowel syndrome (IBS) is a functional bowel disorder of unknown aetiology. There is currently no known cure, and… Expand
2015
2015
Background. Litramine (IQP-G-002AS) was shown to be effective and safe for weight loss in overweight and obese subjects. However… Expand
  • figure 1
  • table 3
  • table 4
  • table 1
  • table 2
2015
2015
The individual ingredients in IQP-VV-102 have demonstrated promising effects in reducing sugar and starch digestion, which… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
2015
2015
*Corresponding author: Emily Teng, InQpharm Group Europe Ltd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia… Expand
  • figure 2
  • table 2
  • figure 1
  • table 1
2014
2014
The safety and efficacy of IQP‐PV‐101, a proprietary extract of Phaseolus vulgaris, on weight management in two phases was… Expand
2014
2014
IQP‐GC‐101 is a patented blend of the standardized extracts of Garcinia cambogia, Camellia sinensis, unroasted Coffea arabica… Expand
Highly Cited
2013
Highly Cited
2013
A proprietary natural fiber complex (Litramine IQP G‐002AS) derived from Opuntia ficus‐indica, and standardized on lipophilic… Expand
2007
2007
This paper proposes a control approach to achieve balanced grid currents in three-level voltage-source inverters connected to the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5